Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Army
Queensland Health
Covington
Mallinckrodt
UBS
Daiichi Sankyo
Colorcon
Boehringer Ingelheim

Generated: August 15, 2018

DrugPatentWatch Database Preview

HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Homatropine Methylbromide And Hydrocodone Bitartrate patents expire, and what generic alternatives are available?

Homatropine Methylbromide And Hydrocodone Bitartrate is a drug marketed by Actavis Elizabeth, Avanthi Inc, and Novel Labs Inc. and is included in three NDAs.

The generic ingredient in HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE is homatropine methylbromide; hydrocodone bitartrate. There are five drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the homatropine methylbromide; hydrocodone bitartrate profile page.

Summary for HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE
Drug patent expirations by year for HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE
Pharmacology for HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE
Drug ClassOpioid Agonist
Mechanism of ActionOpioid Agonists

US Patents and Regulatory Information for HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 040295-001 Dec 1, 2000 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Avanthi Inc HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 207176-001 Aug 7, 2017 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novel Labs Inc HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 091528-001 Apr 20, 2011 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Healthtrust
Mallinckrodt
Chinese Patent Office
Queensland Health
AstraZeneca
Covington
Teva
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.